|
Forthcoming articles
- Yen-Chang Chen & Yen-Yuan Chen, A Moderate Zero Line Approach: Opposing Thresholds Beyond the Zero Line.
- Mark Collen, Letter to the Editor.
- Joshua Crites, Are More Trials Really the Answer? Putting Behavioral Equipoise in Check.
- David Isaacs, Controversial End-of-Life Issues in the Neonatal Intensive Care Unit.
- Alexander A. Kon, Life and Death Choices in Neonatal Care: Applying Shared Decision-Making Focused on Parental Values.
- Alex John London, Equipoise, Research Stalemates, and the Limits of New Data.
- Chris MacDonald, Clinical Judgment and Deep Value Commitments.
- Jerry Menikoff, Overinterpreting Equipoise.
- Rishad R. Motlani, Review of D. Micah Hester, End of Life Care and Pragmatic Decision Making.
- John J. Paris, Standards, Norms, and Guidelines for Permissible Withdrawal of Life Support From Seriously Compromised Newborns.
- Robert M. Sade, The Locus of Decision Making for Severely Impaired Newborn Infants.
- Robert Silbergleit & Peter A. Ubel, Science and Behavior.
- Robert Silbergleit & Peter A. Ubel, Behavioral Equipoise: A Way to Resolve Ethical Stalemates in Clinical Research.
- Anita Silvers & Leslie Francis, Cloudy Crystal Balls Do Not “Gray” Babies Make.
- Robert D. Truog & Sadath A. Sayeed, Neonatal Decision-Making: Beyond the Standard of Best Interests.
- Katherine Wasson, Behavior Equipoise: Is It Ready for Prime Time?
- Dominic James Wilkinson, Shedding Light on the Gray Zone.
- Dominic James Wilkinson, A Life Worth Giving? The Threshold for Permissible Withdrawal of Life Support From Disabled Newborn Infants.
- Sally Bean, Pragmatic and Proportional Analysis of Conflict of Interest.
- Howard Brody, Clarifying Conflict of Interest.
- Howard Brody, Responses to Peer Commentaries on “Clarifying Conflict of Interest”.
- Inmaculada de Melo-Martín, More Clarifications: On the Goals of Conflict of Interest Policies.
- James J. Delaney & David P. Martin, The Role of Physician Opinion in Human Enhancement.
- Katherine Drabiak-Syed, Physicians Prescribing “Medicine” for Enhancement: Why We Should Not and Cannot Overlook Safety Concerns.
- Cynthia Forlini & Eric Racine, Considering the Causes and Implications of Ambivalence in Using Medicine for Enhancement.
- Wayne Hall, Jonathan Finnoff, Jayne Lucke & Brad Partridge, Begging Important Questions About Cognitive Enhancement, Again.
- Thomas D. Harter, Answering Brody's Challenge From a Pharmapologist Perspective.
- Timothy D. Hotze, Kavita Shah, Emily E. Anderson & Matthew K. Wynia, Response to Open Peer Commentaries on “'Doctor, Would You Prescribe a Pill to Help Me … ?' A National Survey of Physicians on Using Medicine for Human Enhancement”.
- Thomas S. Huddle, Clarifying the Dispute Over Academic-Industry Relationships.
- Samia A. Hurst & Alex Mauron, Trustworthiness in Conflict of Interest.
- Elizabeth A. Kitsis, Physicians and the Pharmaceutical Industry: Working Together on Conflict of Interest.
- Paul Komesaroff & Ian Kerridge, It Is Time to Move Beyond a Culture of Unexamined Assumptions, Recrimination, and Blame to One of Systematic Analysis and Ethical Dialogue.
- Jonathan H. Marks & Donald B. Thompson, Shifting the Focus: Conflict of Interest and the Food Industry.
- E. Haavi Morreim, Taking a Lesson From the Lawyers: Defining and Addressing Conflict of Interest.
- Lance K. Stell & Thomas P. Stossel, Another Dip Into the Muddy Waters of COI.
- Daniel Strech & Hannes Knüppel, How to Evaluate Conflict of Interest Policies.
- Alexander C. Tsai, Managing Nonfinancial Conflict of Interest: How the “New McCarthyism” Could Work.
- Katherine Wasson, Medical and Genetic Enhancements: Ethical Issues That Will Not Go Away.
- Bryn Williams-Jones, Beyond a Pejorative Understanding of Conflict of Interest.
- Matthew K. Wynia, Emily E. Anderson, Kavita Shah & Timothy D. Hotze, “Doctor, Would You Prescribe a Pill to Help Me … ?” A National Survey of Physicians on Using Medicine for Human Enhancement.
 | Previous issues |
| | | Next issues |  |
|
|
Off-campus access
Using PhilPapers from home?
Click here to configure this browser for off-campus access.
|
